---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-263520"
form_type: "8-K"
ticker: "WAT"
cik: "0001000697"
company_name: "WATERS CORP /DE/"
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:30:47.200238+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Waters Q3 sales $800M (+8% YoY), non-GAAP EPS $3.40 (+16%), raises FY guidance

## Summary
- Sales $800M, +8% as reported and constant currency, above guidance.
- GAAP EPS $2.50; non-GAAP EPS $3.40, up 16% YoY, above guidance.
- Pharma +11% cc; instruments +6%, recurring +9% cc; chemistry double-digit growth.
- FY25 constant currency sales growth guidance raised to +6.7% to +7.3%; non-GAAP EPS raised to $13.05-$13.15.
- Integration planning for BD Biosciences acquisition progressing; CEO confident in synergies.

## SEC filing metadata
- accession: 0001193125-25-263520
- form_type: 8-K
- ticker: WAT
- cik: 0001000697
- company_name: WATERS CORP /DE/
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000697/000119312525263520/0001193125-25-263520-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000697/000119312525263520/d40092d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-263520
- JSON: https://secwatch.observer/filing/0001193125-25-263520.json
- Plain text: https://secwatch.observer/filing/0001193125-25-263520.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.